Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
AstraZeneca
Accenture
UBS
Fuji
Medtronic
QuintilesIMS
Cipla

Generated: April 22, 2018

DrugPatentWatch Database Preview

ORTHO-EST Drug Profile

« Back to Dashboard

When do Ortho-est patents expire, and when can generic versions of Ortho-est launch?

Ortho-est is a drug marketed by Sun Pharm Inds Inc and is included in two NDAs.

The generic ingredient in ORTHO-EST is estropipate. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the estropipate profile page.
Drug patent expirations by year for ORTHO-EST
Synonyms for ORTHO-EST
[(1S,10R,11S,15S)-15-methyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-5-yl]oxidanesulfonic acid
[(1S,10R,11S,15S)-15-METHYL-14-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2,4,6-TRIEN-5-YL]OXIDANESULFONIC ACID
[(1S,10R,11S,15S)-15-METHYL-14-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2,4,6-TRIEN-5-YL]OXIDANESULFONIC ACID; PIPERAZINE
[(1S,10R,11S,15S)-15-METHYL-14-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2(7),3,5-TRIEN-5-YL]OXIDANESULFONIC ACID; PIPERAZINE
[(8R,9S,13S,14S)-13-methyl-17-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate; piperazine
[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate; piperazine
[3H]-estrone hydrogen sulfate
[3H]-estrone-3-sulphate
[3H]estrone-3-sulfate
[3H]estrone-3-sulphate
1240-04-6 (potassium salt)
17-oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate
17-oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate - piperazine (1:1)
280E377
29080-16-8
3-(Sulfooxy)-estra-1,3,5(10)-trien-17-one : piperazine (1:1)
3-Hydroxyestra-1,3,5(10)-trien-17-one hydrogen sulphate
438-67-5
438-67-5 (hydrochloride salt)
481-97-0
7280-37-7
A837628
AB00514744
AC1MHDJ1
AC1NR4O7
AKOS024457702
AM20080957
AN-23448
AX8127548
BCP9000662
BDBM50366524
BPBio1_000897
BRD-K51095933-231-03-2
BSPBio_000815
C-22322
C02538
CAS-7280-37-7
CC-27537
CCG-220688
CCRIS 9319
CHEBI:17474
CHEBI:4873
CHEMBL1200980
CHEMBL494753
CM14419
Conestoral
Conjugated estrogens: piperazine estrone sulfate
CS-4818
CTK7H2771
CTK8F9509
D00948
D03IUY
D04AXP
DB04574
DR002699
DSSTox_CID_3005
DSSTox_GSID_23005
DSSTox_RID_76828
DTXSID3023005
EINECS 207-575-9
EINECS 230-696-3
Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate
Estra-1,3,5(10)-trien-17-one 3-sulphate, compound with piperazine (1:1)
Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1)
Estra-1(10),2,4-trien-17-one, 3-(sulfooxy)-
Estrogenic substances
estron-3-sulfate
Estrone hydrogen sulfate
Estrone hydrogen sulphate
Estrone 3-sulfate
Estrone 3-sulphate
Estrone bisulfate
Estrone hemisulfate
Estrone hydrogen sulfate
Estrone hydrogen sulfate compound with piperazine (1:1)
estrone hydrogen sulphate
Estrone sulfate
Estrone sulfate piperazine salt
Estrone sulphate
Estrone sulphate sodium
estrone-3-sulfate
estrone-3-sulphate
Estrone, hydrogen sulfate
Estrone, hydrogen sulfate, compd. with piperazine (1:1) (8CI)
Estropipate
Estropipate (USP)
Estropipate [USP:INN:BAN]
Estropipate, >=98% (HPLC), powder
Estropipate, United States Pharmacopeia (USP) Reference Standard
evex
GTPL4748
GTPL4749
Harmogen
HMS1570I17
HMS2097I17
HMS2232O19
HY-B1361
LMST02010043
LS-187148
MFCD00867399
MLS002153957
MolPort-006-167-814
NCGC00016682-02
NCGC00179418-01
Ogen
OGEN .625
Ogen (TN)
OGEN 1.25
OGEN 2.5
OGEN 5
Par Estro
piperazine (8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl sulfate
Piperazine estrone sulfate
Piperazine estronesulfate
Piperazine oestrone sulphate
Piperazine, compd. with 3-(sulfooxy)estra-1,3,5(10)-trien-17-one (1:1) (9CI)
Piperazine, compd. with estrone hydrogen sulfate (1:1) (8CI)
piperazine; sulfuric acid [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] ester
PL000279
PL000390
PL068206
Premarin
Prestwick0_000688
Prestwick1_000688
Prestwick2_000688
Prestwick3_000688
PubChem22728
QTL48N278K
SCHEMBL21577
SCHEMBL22846
SMR001233296
Sodium estrone 3-monosulphate
Sodium estrone 3-sulphate
SPBio_002736
ST24048920
Sulestrex
SVI38UY019
Tox21_113350
UNII-QTL48N278K
UNII-SVI38UY019
ZINC3876186

US Patents and Regulatory Information for ORTHO-EST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc ORTHO-EST estropipate TABLET;ORAL 089567-001 Feb 27, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Inc ORTHO-EST estropipate TABLET;ORAL 089582-001 Jul 17, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chinese Patent Office
Citi
Mallinckrodt
Merck
Cantor Fitzgerald
Medtronic
Cerilliant
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.